Professor Peter Toth

Professor Peter Toth

CGH Medical Center and The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore (United States of America)

Member of:

Presentations Articles

Low-density lipoprotein cholesterol goal attainment with "inclisiran first" versus usual care in patients with atherosclerotic cardiovascular disease

Event: ESC Congress 2024

Topic: Drug therapy

Session: Lipids as risk factor for heart disease

Access

Reduction in the risk of MACE with apabetalone in patients with recent acute coronary syndrome and diabetes according to NAFLD fibrosis score: exploratory analysis of the BETonMACE trial

Event: ESC Congress 2021 - The Digital Experience

Topic: Secondary Prevention

Session: Risk Factors and Prevention ePosters

Access

Final Comments and Summary.

Event: ESC Congress 2020

Topic: Imaging of Coronary Artery Disease

Session: What to know when treating your high-risk patients Today

Access

Welcome and Opening Remarks.

Event: ESC Congress 2020

Topic: Imaging of Coronary Artery Disease

Session: What to know when treating your high-risk patients Today

Access

High risk US adults with untreated hyperlipidaemia in NHANES: estimated reduction in cardiovascular events with statin treatment.

Event: ESC Congress 2020

Topic: Lipids

Session: Risk Factors and Prevention ePosters

Access

Effect of evolocumab on lipoprotein(a) levels: results across 15 studies

Event: ESC Congress 2019

Topic: Drug therapy

Session: Lipids

Access

Triglycerides 150 mg/dL and above are associated with an increased risk of peripheral arterial revascularization in high-risk statin-treated patients: A real-world analysis

Event: ESC Congress 2018

Topic: Epidemiology, Prognosis, Outcome

Session: Peripheral artery disease: clinical

Access

Comparing Friedewald & novel calculations for estimating low-density lipoprotein cholesterol goal attainment using national health and nutrition examination survey data: implications for patient care

Event: ESC Congress 2016

Topic: Epidemiology, lipids

Session: Managing risk from behaviour and environment

Access

Impact of alirocumab on Lp(a) in individuals with and without moderate CKD

Event: ESC Congress 2016

Topic: Lipids

Session: Lipids and platelets

Access

Dependence of glucose levels on triglycerides and body mass index: an analysis using national health and nutrition examination survey data (2003-2012)

Event: ESC Congress 2016

Topic: Epidemiology, lipids

Session: Cardiovascular risk in populations

Access

ESC 365 is supported by

Explore sponsored resources

Professor Peter Toth Follow

Contributor content

Low-density lipoprotein cholesterol goal attainment with "inclisiran first" versus usual care in patients with atherosclerotic cardiovascular disease

Reduction in the risk of MACE with apabetalone in patients with recent acute coronary syndrome and diabetes according to NAFLD fibrosis score: exploratory analysis of the BETonMACE trial

Final Comments and Summary.

Welcome and Opening Remarks.

High risk US adults with untreated hyperlipidaemia in NHANES: estimated reduction in cardiovascular events with statin treatment.

Effect of evolocumab on lipoprotein(a) levels: results across 15 studies

Triglycerides 150 mg/dL and above are associated with an increased risk of peripheral arterial revascularization in high-risk statin-treated patients: A real-world analysis

Comparing Friedewald & novel calculations for estimating low-density lipoprotein cholesterol goal attainment using national health and nutrition examination survey data: implications for patient care

Impact of alirocumab on Lp(a) in individuals with and without moderate CKD

Dependence of glucose levels on triglycerides and body mass index: an analysis using national health and nutrition examination survey data (2003-2012)

ESC 365 is supported by

Professor Peter Toth